Prawo i regulacje · 21/08/2019

DEA Proposes to Remove 6β-Naltrexol From Controlled Substances Schedule

The Drug Enforcement Administration (DEA) is proposing to remove 6β-naltrexol, a Schedule II controlled substance, from the Controlled Substances Act, effectively lifting regulatory controls on its handling and use.